The field of ophthalmic regenerative medicine is poised for significant growth, driven by the increasing prevalence of eye diseases. According to a recent analysis, the Birth Tissue Products Market for these innovative treatments is expected to climb at a robust Compound Annual Growth Rate (CAGR) of 6.6% from 2023 to 2033.
This surge aligns with a broader trend in regenerative medicine, with the ophthalmic segment currently holding a substantial 18.5% share of the global market, valued at approximately US$12.2 billion in 2022.
What is Driving Demand for Birth Tissue Products
The presence of FDA guidelines regarding the tissue management procedures that maintain the integrity of tissue and documentation regarding the safety of tissue which enhances the quality of the tissues, this is driving the birth tissue products market growth.
The birth tissues speed up the recovery for various patients such as wounded military persons and people who face difficulties in the wound healing process.
The wide application of the birth tissues in skin burns, skin cancers, ulcers, and chronic wounds elevated the growth of the market.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-13896
U.S. and Canada Birth Tissue Products Market Outlook
The North American region (US & Canada) dominates the market share of birth tissue products in the world.
The increase in the prevalence of diabetic ulcers in the region opens the route for the birth tissue products market in the region.
The Rapid development in the healthcare sector and the presence of the top key players in the area which leads to a huge investment in R&D is another driving factor of the region
The Health awareness programs by the government and the American Association of Tissue Bank regarding the importance of the donation of birth tissues give a better base for growth.
Fundraising by the government in the healthcare sector plays a major role in the growth of the sector.
Demand & Outlook in Europe& Asia for Birth Tissue Products Market.
The European region holds the second position in the birth tissue products market, the increase in the patients of skin cancers in the region leads to the growth of the market in the region.
The healthcare awareness programs improve the knowledge of people regarding the healing powers of the birth tissues and help boost the market in the region.
Asia Pacific region is the fastest growing and developing region in the world which results in increasing government funding in the healthcare sector, research and development sector which defines the growth of the market in the region.
The increase in population in the region plays a major role in the increase in demand for the birth tissue market as the number of newborn babies increases every year, which significantly gives a great opportunity to set a base for the birth tissue products market in the region
Key Players: According to FMI analysis are:
- Amiox medical
- tissue inc
- AATB
- U.S. Stem Cell Inc
- Vericel Corp. (Aastrom Biosciences Inc.)
- Organogenesis Inc. (Advanced Biohealing)
- Cerapedics Inc
- Mesoblast Ltd.
- Ocata Therapeutics Inc. (Astellas Pharma Inc.)
- Tissue Recover(Alpha Cord)
- BTR(Birth Tissue Recovery)LLC
- Tellagen LLC
- Predictive Biotech
The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain.
Customize Your Report for Maximum Impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-13896
Birth Tissue Products Market Key Segments
By Type of Tissue:
- Placenta
- Umbilical cord
- Amniotic Fluid
By Application:
- Cardiovascular disorders
- Oncology
- Dermatology
- Musculoskeletal
- Wound healing
- Ophthalmology
By End User:
- Research Laboratories
- Academic Institutes
- Pharma and Biotech Companies
- Hospitals and Diagnostic centers
- Others
By Region:
- Oceania
- South Asia
- East Asia
- Europe
- Latin America
- North America
- Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube